Hodgkin's disease: multidisciplinary contributions to the conquest of a neoplasm. Erskine memorial lecture, 1976
- PMID: 404663
- DOI: 10.1148/123.3.551
Hodgkin's disease: multidisciplinary contributions to the conquest of a neoplasm. Erskine memorial lecture, 1976
Abstract
In the 150 years since the first description of Hodgkin's disease, treatment methods have become increasingly sophisticated and effective. We now know that relapses are concentrated within the first five years after treatment. Accordingly, anyone who survives the first five years has a 95% chance of cure. Modern techniques in diagnosis, staging, and combined chemotherapy and irradiation have brought us within sight of total therapeutic conquest of this once inexorably fatal malady.
Similar articles
-
[Significance of exploratory laparotomy and splenectomy in the classification and choice of therapeutic methods in the treatment of Hodgkin's disease].Pol Tyg Lek. 1972 Sep 18;27(38):1490-2. Pol Tyg Lek. 1972. PMID: 4627715 Review. Polish. No abstract available.
-
[Hodgkin's disease; a regional retrospective study].Ned Tijdschr Geneeskd. 1988 Sep 24;132(39):1801-6. Ned Tijdschr Geneeskd. 1988. PMID: 3141820 Dutch. No abstract available.
-
Hodgkin's disease in Denmark. A national clinical study by the Danish Hodgkin Study Group, LYGRA.Scand J Haematol. 1980 Apr;24(4):321-34. Scand J Haematol. 1980. PMID: 6932097
-
[Splenectomy in Hodgkin's disease--indication and results (author's transl)].Arch Geschwulstforsch. 1976;46(4):311-5. Arch Geschwulstforsch. 1976. PMID: 971047 German.
-
Hodgkin's disease. Recent concepts in management.N Y State J Med. 1972 Sep 1;72(17):2189-95. N Y State J Med. 1972. PMID: 4560043 Review. No abstract available.
Cited by
-
Uptake of 67Ga-6-mercaptopurines in Morris hepatoma-3924 A.Eur J Nucl Med. 1979 Jun 1;4(3):211-5. doi: 10.1007/BF00620488. Eur J Nucl Med. 1979. PMID: 499242
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources